Sklerózis

Sklerózis, also known as scleroderma, is a chronic autoimmune disease that affects the connective tissue of the skin and other organs. It is characterized by the excessive production of collagen and other fibrous proteins, leading to the thickening and hardening of the skin. The most common form is localized scleroderma, which affects only the skin, while systemic scleroderma involves internal organs and can be life-threatening.

The cause of sklerózis is not fully understood, but it is believed to be triggered by an abnormal immune response. Genetic factors, environmental exposures, and hormonal influences may also play a role. The disease can affect people of all ages, but it is more common in women and often appears between the ages of 30 and 50.

Symptoms of sklerózis vary depending on the type and severity of the disease. Localized scleroderma may cause tight, hard patches of skin, while systemic scleroderma can lead to joint pain, fatigue, and damage to internal organs such as the heart, lungs, and kidneys. Raynaud's phenomenon, a condition characterized by the narrowing of blood vessels in response to cold or stress, is also common in people with scleroderma.

There is no cure for sklerózis, but treatments can help manage symptoms and improve quality of life. These may include medications to relax muscles, reduce inflammation, or suppress the immune system, as well as physical therapy and occupational therapy to maintain mobility and function. Support groups and counseling can also provide emotional support for people with scleroderma and their families.

Research is ongoing to better understand the causes and treatments for sklerózis. Early diagnosis and intervention can improve outcomes, so it is important for individuals with symptoms to consult with a healthcare provider.